RecruitingNot ApplicableNCT07622654

Effect of Emotion-Focused Acceptance and Commitment Therapy on Obsessive-Compulsive Disorder Symptom Severity

The Effect of Emotion-Focused Acceptance and Commitment Therapy on Obsessive-Compulsive Disorder Symptom Severity: A Randomized Controlled Trial


Sponsor

Mehmet Emrah Karadere

Enrollment

36 participants

Start Date

Oct 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to investigate the effect of Emotion-Focused Acceptance and Commitment Therapy (ACT) group psychotherapy on obsessive-compulsive disorder (OCD) symptom severity. Participants with OCD will be randomly assigned to either an ACT-based group psychotherapy arm or a supportive group psychotherapy arm. Each arm consists of 10 to 12 weekly sessions of 2 hours. Symptom severity, psychological flexibility, emotional awareness, functioning and quality of life will be assessed before and after the intervention.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria4

  • Diagnosis of Obsessive-Compulsive Disorder according to DSM-5 criteria
  • Age between 18-65 years
  • Minimum literacy level
  • Willingness to participate and providing informed consent

Exclusion Criteria6

  • Age over 65 years
  • Diagnosis of alcohol or substance use disorder
  • Comorbid psychotic disorder or intellectual disability
  • Any change in psychiatric treatment (medication or psychotherapy) in the last 3 months
  • Comorbid psychiatric disorder that would impair group therapy compliance
  • History of cognitive impairment due to dementia, organic brain syndrome or other neurological/organic pathology

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALEmotion-Focused Acceptance and Commitment Therapy (ACT) Group Psychotherapy

Structured group psychotherapy based on ACT principles targeting emotional awareness, acceptance of emotional experiences, cognitive defusion, present-moment focus, values clarification and committed action. Sessions are conducted face-to-face, once weekly, 2 hours per session, for 10-12 weeks.


Locations(1)

Goztepe Prof. Dr. Suleyman Yalcin City Hospital

Istanbul, Istanbul, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07622654


Related Trials